![Figure 4. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology Figure 4. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology](https://www.jrheum.org/content/44/4/519/F4.large.jpg)
Figure 4. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
![IJMS | Free Full-Text | The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic IJMS | Free Full-Text | The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic](https://pub.mdpi-res.com/ijms/ijms-21-07041/article_deploy/html/images/ijms-21-07041-g001.png?1602311032)
IJMS | Free Full-Text | The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic
![PDF) Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative PDF) Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative](https://i1.rgstatic.net/publication/280120891_Evidence-based_Recommendations_for_the_Management_of_Comorbidities_in_Rheumatoid_Arthritis_Psoriasis_and_Psoriatic_Arthritis_Expert_Opinion_of_the_Canadian_Dermatology-Rheumatology_Comorbidity_Initiat/links/571e76b908aefa648899a173/largepreview.png)
PDF) Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative
![Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of ... Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of ...](https://bmjopen.bmj.com/content/bmjopen/13/9/e078539/F1.large.jpg)
Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of ...
![Predicting response to therapy among patients with psoriatic arthritis - results from the British Society of Rheumatology Psoriatic Arthritis Register (BSR-PsA) - GRAPPA Network Predicting response to therapy among patients with psoriatic arthritis - results from the British Society of Rheumatology Psoriatic Arthritis Register (BSR-PsA) - GRAPPA Network](https://www.grappanetwork.org/wp-content/uploads/2023/07/GRAPPA-Poster-A0-landscape-S.Lembke_v03-pdf.webp)
Predicting response to therapy among patients with psoriatic arthritis - results from the British Society of Rheumatology Psoriatic Arthritis Register (BSR-PsA) - GRAPPA Network
![Figure 1. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology Figure 1. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology](https://www.jrheum.org/content/44/4/519/F1.large.jpg)
Figure 1. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
![2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis - Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis - Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan](https://journals.sagepub.com/cms/10.1177/2475530318812244/asset/images/large/10.1177_2475530318812244-fig3.jpeg)
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis - Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan
![Prevalence of Disease Domain Presentations Among Patients with Psoriatic Arthritis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry - ACR Meeting Abstracts Prevalence of Disease Domain Presentations Among Patients with Psoriatic Arthritis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-685401-1-ANY-1-.jpg)
Prevalence of Disease Domain Presentations Among Patients with Psoriatic Arthritis: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry - ACR Meeting Abstracts
![Figure 6. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology Figure 6. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology](https://www.jrheum.org/content/44/4/519/F6.large.jpg)
Figure 6. | Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
![Frontiers | Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis Frontiers | Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis](https://www.frontiersin.org/files/Articles/723944/fmed-08-723944-HTML/image_m/fmed-08-723944-g001.jpg)
Frontiers | Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
![Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway - European Medical Journal Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2020/07/Figure-1-The-cytokine-environment.png)
Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway - European Medical Journal
![Evaluating practice patterns for managing moderate to severe plaque psoriasis | The College of Family Physicians of Canada Evaluating practice patterns for managing moderate to severe plaque psoriasis | The College of Family Physicians of Canada](https://www.cfp.ca/content/cfp/58/7/e390/F1.large.jpg)
Evaluating practice patterns for managing moderate to severe plaque psoriasis | The College of Family Physicians of Canada
![Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis | Advances in Rheumatology | Full Text Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis | Advances in Rheumatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42358-021-00219-y/MediaObjects/42358_2021_219_Fig1_HTML.png)
Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis | Advances in Rheumatology | Full Text
![Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Guidelines Pocket Guides & Apps - Guideline Central Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Guidelines Pocket Guides & Apps - Guideline Central](https://www.guidelinecentral.com/wp-content/uploads/2017/11/GRAPPA-PsA-v3a-cover-800px.png)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Guidelines Pocket Guides & Apps - Guideline Central
![Precision medicine in psoriatic arthritis: how should we select targeted therapies? - The Lancet Rheumatology Precision medicine in psoriatic arthritis: how should we select targeted therapies? - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/fa695f1c-0869-40b5-9d61-36a519f78bb3/gr1.jpg)
Precision medicine in psoriatic arthritis: how should we select targeted therapies? - The Lancet Rheumatology
![Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology - ScienceDirect Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0929664620304009-gr1.jpg)
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology - ScienceDirect
![Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 | Nature Reviews Rheumatology Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 | Nature Reviews Rheumatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41584-022-00798-0/MediaObjects/41584_2022_798_Fig2_HTML.png)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 | Nature Reviews Rheumatology
![The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/104e0f86-069f-4393-b49a-4624140bd4a7/gr1.jpg)
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
![Psoriatic Arthritis Treatment in Homeopathy | Best Homeopathic Medicine for Arthritis and Joint Pain and Knee Pain Psoriatic Arthritis Treatment in Homeopathy | Best Homeopathic Medicine for Arthritis and Joint Pain and Knee Pain](https://www.lifeforce.in/Images/psoriatic%20arthritis%20bn1.jpg)
Psoriatic Arthritis Treatment in Homeopathy | Best Homeopathic Medicine for Arthritis and Joint Pain and Knee Pain
![IJMS | Free Full-Text | Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints IJMS | Free Full-Text | Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints](https://pub.mdpi-res.com/ijms/ijms-19-00530/article_deploy/html/images/ijms-19-00530-ag.png?1569853719)